The chemical class known as CARD14 Activators encompasses a range of compounds that specifically target and upregulate the expression or function of the CARD14 protein, a key player in the regulation of immune responses and inflammatory processes, particularly in skin cells. These activators work by engaging with the cellular and molecular pathways that control the activity of CARD14, which is integral to the signaling mechanisms within the immune system and skin homeostasis. The precise mechanism of action for each activator can vary, but generally, these compounds interact with the CARD14 protein or its regulatory elements at the genetic level, thereby influencing its expression or functional state. Some of these activators may work by binding directly to CARD14, altering its conformation, and thus its activity. Others might interact with upstream regulators or signaling pathways that converge on CARD14, thereby modulating its activation state or expression levels.
In the context of cellular biology, CARD14 activators are particularly significant due to their role in influencing the pathways associated with inflammation and immune responses in the skin. These activators can have varying effects depending on their specific mechanism of action and the context of their use. For example, some might enhance the ability of CARD14 to initiate signaling cascades that lead to the production of inflammatory cytokines, while others might increase the overall expression level of CARD14, thereby amplifying its role in the cellular processes. The activation of CARD14 is closely tied to the regulation of NF-kB pathways, a central component in the control of immune response and cell survival. Thus, CARD14 activators are pivotal in the modulation of these critical biological processes. Their relevance extends to understanding the complex interactions within the skin's immune environment and the broader implications for skin cell behavior and responses to various stimuli, including stress and pathogens.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid could enhance CARD14 expression by influencing skin cell differentiation and proliferation, potentially upregulating genes involved in inflammatory responses. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol may promote CARD14 expression through its role in immune regulation and skin health, possibly by enhancing the activity of pathways involved in inflammation. | ||||||
Salicylic acid | 69-72-7 | sc-203374 sc-203374A sc-203374B | 100 g 500 g 1 kg | $47.00 $94.00 $119.00 | 3 | |
Salicylic Acid, through its role in skin health, might upregulate CARD14 by enhancing cellular responses to inflammation and possibly promoting skin cell turnover. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide, a form of vitamin B3, could upregulate CARD14 by affecting cellular metabolism and responses to skin stressors, potentially leading to increased expression in skin cells. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, might upregulate CARD14 expression through its anti-inflammatory effects, potentially altering signaling pathways in skin cells. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin could potentially increase CARD14 expression by modulating inflammation and oxidative stress pathways, which are involved in skin health and immune responses. | ||||||